Table 4.
Prevalence of HCV Infection in End Stage Renal Disease Patients in Various Indian Studies.
| Author | Place | Year | Total no. of patients | Patients with HCV infection (%) | Method |
|---|---|---|---|---|---|
| Salunkhe2 | Lucknow | 1992 | 31 | 45% | anti-C100-3 antibody assay |
| Chadha3 | Pune | 1993 | 12.1% | ||
| Sumathy4 | South India | 1993 | 37.5% | ||
| Arankalle5 VA | Pune | 1995 | 57 | 24.5% | 3rd Gen RIBA |
| Jaiswal SP6 | Indore | 1996 | 105 | 41.9% | Ant HCV ELISA |
| Gosavi7 | Mumbai | 1997 | 72 | 27.8% | Anti HCV 2nd Gen ELISA |
| Agrawal SK8 | Delhi | 1999 | 69 | 42% | |
| Chandra M9 | Hyderabad | 2004 | 256 | 46% | Anti HCV ELISA and HCV RNA |
| Reddy10 | Hyderabad | 2005 | 151 | 13.23% | Anti HCV & HCVcAg by ELISA |
| Medhi11 | Delhi | 2008 | 250 | 17.2% | Anti HCV & HCVcAg by ELISA |
| Jasuja12 | Delhi | 2009 | 119 | 27.7% | HCV PCR |